Condition: Stress Urinary Incontinence · Sponsor: Uromedica
The ProACT Post Approval Study is a 5-year prospective, open-label, multi-center study designed to evaluate the long-term incidence of urethral stricture and device erosion after ProACT implantation. In addition, the study will evaluate whether treatment with ProACT affects clinical outcomes after subsequent SUI therapies.
This description comes directly from the study's public registry record.
Patrick Gora · 7636949880 · pgora@uromedica-inc.com
Timothy C Cook, PhD · 7636949880 · regulatory@uromedica-inc.com
Always discuss trial participation with your own doctor first.
| University of Colorado | Denver, Colorado, United States | Recruiting |
| University of Florida | Gainesville, Florida, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| University of Kansas Medical Center | Kansas City, Kansas, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| CentraCare- St. Cloud | Saint Cloud, Minnesota, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03767595